About Zoe

Since joining the organisation in 2020, Zoe has helped support a growing body of work at the intersection of patient voice, science, and practical change for people living with lupus across Europe.

Living with lupus, antiphospholipid syndrome, and other rare conditions herself, Zoe brings both lived and professional experience to her work. She is particularly interested in how patient insight can be built in from the start, not added at the end, and in how collaboration between patients, clinicians, researchers, and other stakeholders can lead to work that is both rigorous and genuinely useful.

Within LUPUS EUROPE, Zoe leads or supports a wide range of initiatives, from day to day operations to scientific collaborations, and new projects such as LupusGPT, a multilingual patient-led AI tool designed to provide free, accessible, reliable lupus information. A recurring thread in her work is the wish to help translate complexity into something clearer, more human, and more usable for patients.

Zoe is also a Fellow in the Lupus Europe Patient Advisory Network (PAN), a group of trained patient representatives working with the scientific and medical community on research. In addition, she is an ePAG representative for SLE within ERN ReCONNET.

Zoe is especially drawn to work that is careful, collaborative, and transferable, work that can hold complexity without losing clarity, humanity, or usefulness, and that helps create models, tools, and ways of working that others can build on too.

Live Facebook Feed

Comments Box SVG iconsUsed for the like, share, comment, and reaction icons

💧 You’ve probably heard about “liquid biopsy”, a promising concept in lupus research.

But do you actually know what it means?
And why is everyone talking about it?

🤔 Could it help detect lupus nephritis and keep track of how it evolves using less invasive methods?

In this short video from our #ELM2026 series, Dr Andrea Fava breaks it down in a clear and patient-friendly way.

🎥 Watch the video and find out!

youtu.be/GnRbBK7x5hs?si=DzGfLGNW0tp_UMn-

🚨 Don't miss out and visit the #ELM2026 playlist with all videos in the "Video on Demand" section of our website! www.lupus-europe.org/videos-on-demand/

🙏 Thank you, Dr Andrea Fava, for your generosity in taking the time to share your knowledge in such a clear and accessible way, helping bring complex medical information closer to people living with lupus.
... See MoreSee Less

💧 You’ve probab

📅 𝗠𝗮𝗿𝗸 𝘆𝗼𝘂𝗿 𝗰𝗮𝗹𝗲𝗻𝗱𝗮𝗿❗

🤩 Lupus Europe is excited to invite you to a unique event on World Lupus Day:

🧑‍💻 “Fertility, family planning for young lupus patients”

🚀 𝗔 𝘄𝗲𝗯𝗶𝗻𝗮𝗿 𝗼𝗿𝗴𝗮𝗻𝗶𝘀𝗲𝗱 𝗮𝗻𝗱 𝗹𝗲𝗱 𝗯𝘆 the Lupus Europe 𝗬𝗼𝘂𝘁𝗵 𝗚𝗿𝗼𝘂𝗽.

📆 10th of May.
🕖 19:00 h CET.

🙌 A space dedicated to discussing issues that impact young people, by young and for young people.

This event is a tremendous opportunity to connect, learn, and share experiences related to lupus from the perspective of young people.

👩‍⚕️ Joining us will be Prof Laura Andreoli, who will answer your questions and engage in meaningful conversation with Lynette, Makya, Marina and Rita from the Lupus Europe Youth Group.

Moderated by our Chair, Jeanette Andersen.

‼️Register now by sending an e-mail to secretariat@lupus-europe.org‼️
... See MoreSee Less

📅 𝗠𝗮𝗿�

🌍 This month in our #1Month1Study campaign, we highlight our “Living with systemic lupus erythematosus in 2020: a European patient survey”, published in Lupus Science & Medicine.

This large-scale study, conducted by Lupus Europe was led by Alain Cornet, Jeanette Andersen, Kirsi Myllys, Angela Edwards with the incredible support of Prof. Laurent Arnaud. The study analysed data from 4,375 patients across 35 European countries, providing one of the most comprehensive overviews of the burden of SLE in Europe from the patient perspective.

✅ Key findings include:

•⁠ ⁠A median diagnosis delay of 2 years, highlighting persistent gaps in early recognition.
•⁠ ⁠A high symptom burden, with a median of 9 symptoms per patient.
•⁠ ⁠Significant impact on education, employment, and daily functioning.
•⁠ ⁠Marked inequalities in access to care across countries.

📌 These data underline the importance of integrating the patient perspective into clinical practice, research, and health policy to improve outcomes in this complex disease.

doi.org/10.1136/lupus-2020-000469

😃 Stay tuned as we break down these findings throughout the month and explore what they mean for people living with lupus across Europe.

This study would not have been possible without the active support and dissemination of Lupus Europe National Members across Europe. A huge thank you to all National Members and to all who supported and disseminated the study, for making this possible for the lupus community.
... See MoreSee Less

🌍 This month in o
LUPUS EUROPE Uniting people with Lupus throughout Europe
Send